Year: 2024

Cara Therapeutics and Tvardi Therapeutics Announce Entry into Merger Agreement

Written by Customer Service on December 18, 2024. Posted in Mergers And Acquisitions.

Proposed Merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company developing novel treatments targeting STAT3 to treat fibrosis-driven diseases Tvardi has recently completed an approximately $28 million private financing, which, together with Tvardi’s existing cash and Cara’s anticipated cash balance, is expected to fund the combined company into the second half of 2026 Tvardi anticipates reporting topline data in the second half of 2025 from two Phase 2 clinical programs utilizing its STAT3 inhibitor, TTI-101, including its lead program in idiopathic pulmonary fibrosis and its program in hepatocellular carcinoma Companies to host investor conference call and webcast today, December 18th, at 8:30am ET STAMFORD, Conn. and HOUSTON, Dec. 18, 2024 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA) and Tvardi...

ABM Reports Fourth Quarter and Full Fiscal 2024 Results and Provides Fiscal 2025 Outlook

Written by Customer Service on December 18, 2024. Posted in Earnings Releases And Operating Results.

Revenue of $2.2 billion in the fourth quarter, including 3.2% organic growth Net loss of $11.7 million and GAAP loss per share of $0.19 in the fourth quarter, largely reflecting a $59.7 million adjustment to the RavenVolt acquisition cash earn-out Adjusted EBITDA of $128.0 million in the fourth quarter Adjusted EPS of $0.90 in the fourth quarter Repurchased $32.0 million of common stock in the fourth quarter and $55.8 million for full fiscal 2024 Raises quarterly dividend 18%, as previously announced Fiscal 2025 adjusted earnings per share expected to be in range of $3.60 to $3.80 (1)NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of facility solutions, today announced financial results for the fourth quarter and full year ended October 31, 2024. “ABM finished the year well, with double-digit...

Polyrizon’s Moving Forward with Expected 2025 Clinical Trial – Entered Manufacturing Agreement for its PL-14 Allergy Blocker

Written by Customer Service on December 18, 2024. Posted in Public Companies.

The engagement with an EU-based GMP manufacturing facility enables timely production and preparation for clinical trial. The EU-based GMP manufacturer has large-scale commercial production capabilities, to support Polyrizon in future commercialization efforts Raanana, Israel, Dec. 18, 2024 (GLOBE NEWSWIRE) — Polyrizon Ltd. (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, previously announced that it entered into a manufacturing agreement with Eurofins CDMO Amatsiaquitaine S.A.S, a leading European-based Good Manufacturing Practice (GMP) manufacturer. This collaboration will supply Clinical Trial Material (CTM) for Polyrizon’s PL-14 allergy blocker, in preparation for a clinical trial that is expected to commence in 2025. With...

Form 8.5 (EPT/RI)-De La Rue plc

Written by Customer Service on December 18, 2024. Posted in Public Companies.

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Name of exempt principal trader: Investec Bank plc(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree De La Rue plc(c) Name of the party to the offer with which exempt principal trader is connected: Investec is Joint Broker to De La Rue plc(d) Date dealing undertaken: 17th December 2024(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state...

Andes Technology Partners with ProvenRun to Strengthen RISC-V Trusted Execution Environment

Written by Customer Service on December 18, 2024. Posted in Public Companies.

Taipei, Taiwan, Dec. 18, 2024 (GLOBE NEWSWIRE) — Andes Technology Corporation (TWSE: 6533), the leading supplier of RISC-V processor IP, and ProvenRun, the leading secure OS vendor for connected vehicles and smart devices, announce their partnership to offer ProvenRun’s formally proven Secure OS and Trusted Execution Environment (TEE) on Andes’ RISC-V processors. As security threats increase, device and data protection is critical for consumers and governments alike. Preventing information leaks and safeguarding systems from misuse requires embedded systems and IoT devices to integrate advanced security features. Hardware and software isolation, in particular, is essential to prevent unauthorized access to sensitive information in device memory. Andes Technology has played a central role in enhancing RISC-V security standards,...

Auction of Treasury Bills on 20 December 2024

Written by Customer Service on December 18, 2024. Posted in Public Companies.

The treasury bills for sale have the following stock exchange codes: Name Stock exchange code MaturityDGTB 03/03/25 25 / I 98-19740 3 March 2025DGTB 02/06/25 25 / II 98-19823 2 June 2025The sale will settle on 2 January 2025 at the stop-rate for each serie. In case of bid on stop-rate a pro-rata ratio may occur. The deadline for bidding is 10.15 on the day of the auction.

Avance Gas Holding Ltd: Completed the eleventh VLGC delivery to BW LPG successfully

Written by Customer Service on December 18, 2024. Posted in Public Companies.

Hamilton, Bermuda. December 18, 2024 Avance Gas Holding Ltd (“Avance Gas” or “Company”) (OSE:AGAS) refers to the announcement on August 15, 2024, regarding the sale of its VLGC fleet, consisting of twelve vessels, to BW LPG Ltd (“BW LPG” or “Buyer”). Avance Gas announces today the eleventh VLGC delivery, the 2015-built scrubber- fitted vessel, Monsoon. In connection with the delivery, 1.35 million shares in BW LPG were issued by the Buyer to Avance Gas. Additionally, the Company also received net cash proceeds of approximately $22 million after repayment of outstanding debt. Following the delivery, Avance Gas owns 17.141 million shares in BW LPG corresponding to a 10.91% ownership share. The last remaining VLGC, Avance Avior, to be delivered to BW LPG is currently scheduled for delivery on...

Nykredit Realkredit A/S publish supplement no 3 to joint Euro Medium Term Note Programme – Nykredit Realkredit A/S

Written by Customer Service on December 18, 2024. Posted in Public Companies.

To Nasdaq CopenhagenNykredit Realkredit A/S publish supplement no 3 to joint Euro Medium Term Note Programme Nykredit Realkredit A/S publish supplement no 3 dated 8 November 2024 to €15,000,000,000 Euro Medium Term Note Programme (“EMTN Programme“) dated 8 May 2024. Under the EMTN Programme Nykredit Realkredit A/S may issue Subordinated Notes (Tier 2), Senior Non-Preferred Notes and Senior Unsecured Notes. The supplement and the EMTN Programme are available for download on Nykredit’s website at nykredit.com/ir. Questions may be addressed to Morten Bækmand Nielsen, Head of ALM & Investor Relations, tel +45 44 55 15 21 or Kristian Ingemann Petersen, Attorney-at-Law, tel +45 44 55 16 78.AttachmentsNykredit Realkredit publish supplementSupplement no 3 for Base Prospectus...

New Hydrogen CEO Steve Hill and University of Michigan Expert Discuss Energy Infrastructure Coordination and Data Security

Written by Customer Service on December 18, 2024. Posted in Public Companies.

Dr. Vladimir Dvorkin shares his experience in coordinating critical infrastructures such as power grid with data centers, safeguarding energy data privacy, and evolving role of AI SANTA CLARITA, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) — NewHydrogen, Inc. (OTCMKTS:NEWH), the developer of ThermoLoop™, a breakthrough technology that uses water and heat rather than electricity to produce the world’s cheapest green hydrogen, today announced a podcast featuring CEO Steve Hill and Dr. Vladimir Dvorkin, Assistant Professor of Electrical Engineering and Computer Science at the University of Michigan. As for coordinating infrastructure like power grid and data centers, Dr. Dvorkin said, “Data centers are newly emerging pieces of infrastructure to have a huge impact on power grid. Electrical load can rapidly change due to sudden change...

DNA Plc’s disclosure obligation is coming to an end: Financial information and Annual General Meeting in 2025

Written by Customer Service on December 18, 2024. Posted in Public Companies.

DNA PLC STOCK EXCHANGE RELEASE 18 December 2024, 11:00 am EET The bond issued by DNA Plc (ISIN: FI4000312095), listed on Nasdaq Helsinki, matures on 27 March 2025 at the latest. As DNA is only subject to the disclosure obligation in relation to this maturing bond, the disclosure obligation will end at the maturity of the bond. For this reason, DNA will not publish its own financial statements for 2024 and therefore no financial statements bulletin, either. DNA’s official financial figures for 2024 will be published as part of the stock exchange reporting of its parent company, the Norwegian communications services group Telenor ASA. Telenor ASA will publish its financial statements on 6 February 2025 and its annual report, including the financial statements, on 20 March 2025. DNA will continue as usual to communicate its current...

Year: 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals